Busulfan: interakcje

Hepatic veno-occlusive disease, which may be life threatening, has been reported in patients receiving busulfan, usually in combination with cyclophosphamide or other chemotherapeutic agents prior to bone marrow transplantation. (etykieta leku Busulfan, Ostrzeżenia)

Busulfan : Increased busulfan serum concentrations; avoid concomitant use, monitor for plasma concentrations and adjust the busulfan dose accordingly. (etykieta leku Metronidazol, Interakcje z innymi lekami)

Do not administer bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride concomitantly with busulfan unless the benefit outweighs the risk. (etykieta leku Zasadowy cytrynian bizmutu + metronidazol + tetracyklina, Ostrzeżenia i środki ostrożności)

Deferasirox increases exposure of busulfan. (etykieta leku Deferazyroks, Interakcje z innymi lekami)

Hemorrhagic cystitis is dose‑dependent and the risk is increased with past or concomitant radiation of the bladder or busulfan treatment. (etykieta leku Ifosfamid, Ostrzeżenia i środki ostrożności)

The concomitant systemic administration of itraconazole to patients receiving high-dose MYLERAN may result in reduced busulfan clearance (see CLINICAL PHARMACOLOGY). (etykieta leku Busulfan, Interakcje z innymi lekami)

Hepatic Veno-Occlusive Disease Hepatic veno-occlusive disease may occur in patients who have received high-dose TEPADINA in conjunction with busulfan and cyclophosphamide [ see Adverse Reactions (6.1) ]. (etykieta leku Tiotepa, Ostrzeżenia i środki ostrożności)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (etykieta leku Busulfan, Ostrzeżenia)

Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (etykieta leku Busulfan, Ostrzeżenia)

Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (etykieta leku Busulfan, Ostrzeżenia)

During the pregnancy that resulted in the malformed infant, the mother received x-ray therapy early in the first trimester, mercaptopurine until the third month, then busulfan until delivery. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)

Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (etykieta leku Busulfan, Ostrzeżenia)

Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (etykieta leku Busulfan, Ostrzeżenia)

Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (etykieta leku Busulfan, Ostrzeżenia)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (etykieta leku Busulfan, Ostrzeżenia)